MRK.HM Merck & Company Inc
- Market cap
- -
- P/E
- 27.5x
- P/B
- 2.17x
- ROE
- 7.6%
- Dividend yield
- 1.35%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is MRK.HM undervalued?
Graham numberThe Graham number of Merck & Company Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Merck & Company Inc fundamental analysis
No fundamental analysis for Merck & Company Inc yet.
Merck & Company Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Merck & Company Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Merck & Company Inc annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 15.0B | 15.3B | 14.8B | 16.2B | 17.5B | 19.7B | 22.2B | 21.0B | 21.2B | 21.1B | 21.1B |
| Gross Profit | 9.82B | 10.0B | 9.45B | 10.1B | 10.7B | 12.3B | 13.7B | 12.4B | 12.5B | 12.3B | 12.5B |
| Operating Income | 1.89B | 1.71B | 1.37B | 1.68B | 2.81B | 4.21B | 4.75B | 3.57B | 4.01B | 3.66B | 3.38B |
| EBITDA | - | 4.33B | 3.61B | 4.16B | 4.96B | 5.96B | 6.55B | 5.69B | 5.96B | 5.99B | 5.62B |
| Net Income | 1.63B | 2.60B | 3.37B | 1.32B | 1.99B | 3.06B | 3.33B | 2.82B | 2.78B | 2.61B | 2.30B |
| EPS | - | 5.98 | 7.76 | 3.04 | 4.57 | 7.03 | 7.65 | 6.50 | 6.39 | 6.00 | 5.29 |
| Balance Sheet | |||||||||||
| Total Assets | 38.3B | 35.6B | 36.9B | 43.8B | 41.8B | 45.4B | 48.5B | 48.5B | 51.6B | 51.5B | 52.7B |
| Total Liabilities | 24.2B | 21.6B | 19.7B | 25.9B | 24.8B | 23.9B | 22.5B | 21.7B | 21.6B | 22.9B | 22.4B |
| Shareholders' Equity | 14.0B | 14.0B | 17.2B | 17.9B | 16.9B | 21.3B | 25.9B | 26.7B | 29.9B | 28.6B | 30.2B |
| Cash & Short-term Investments | 939M | 589M | 2.17B | 541M | 1.11B | 1.51B | 1.40B | 1.58B | 2.15B | 2.33B | 1.96B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 2.52B | 2.70B | 2.22B | 2.86B | 3.48B | 4.62B | 4.26B | 3.78B | 4.59B | 3.93B | 2.85B |
| Capital Expenditure | 848M | 1.31B | 1.02B | 1.02B | 1.56B | 1.42B | 1.81B | 2.02B | 2.18B | 1.96B | 1.73B |
| Free Cash Flow | - | 1.39B | 1.20B | 1.84B | 1.91B | 3.20B | 2.45B | 1.76B | 2.40B | 1.97B | 1.11B |
| Ratios | |||||||||||
| ROE | 11.6% | 18.6% | 19.6% | 7.4% | 11.7% | 14.3% | 12.8% | 10.6% | 9.3% | 9.1% | 7.6% |
| ROA | 4.3% | 7.3% | 9.1% | 3.0% | 4.8% | 6.7% | 6.9% | 5.8% | 5.4% | 5.1% | 4.4% |
| Net Profit Margin | 10.8% | 17.0% | 22.7% | 8.2% | 11.3% | 15.5% | 15.0% | 13.5% | 13.1% | 12.4% | 10.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Merck & Company Inc dividends
- Dividend yield
- 1.35%
- Forward dividend
- -
- Payout ratio
- 10.9%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 284M | 0.65 | 10.9% |
| 2024 | EUR 284M | 0.65 | 10.2% |
| 2023 | EUR 284M | 0.65 | 10.1% |
| 2022 | EUR 239M | 0.55 | 7.2% |
| 2021 | EUR 181M | 0.42 | 5.9% |
| 2020 | EUR 168M | 0.39 | 8.5% |
| 2019 | EUR 162M | 0.37 | 12.3% |
| 2018 | EUR 755M | 1.74 | 22.4% |
| 2017 | EUR 621M | 1.43 | 23.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Jun 30, 2014.
Who owns Merck & Company Inc
Ownership data of Merck & Company Inc is not available yet.
Merck & Company Inc company profile
- Company name
- Merck & Company Inc
- Ticker
- MRK.HM
- ISIN
- DE0006599905
- Exchange
- Hamburg Exchange
- Sector
- Other
- Industry
- Metals & Mining
- Fiscal year end
- December
- Address
- Website
- -
About Merck & Company Inc
There is no Profile data available for MRK.HM.